Ask Warren

Y2 Solution

011690 · KOSPI · ₩011690 · 와이투솔루션

₩3,010▼ ₩205 (6.38%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
News · Etoday·

Y2 Solution's US joint venture shows promising results for dry age-related macular degeneration cell therapy in clinical trial; vision improvement maintained for 2 years

Y2 Solution₩3,010▼6.38%
Read the original ↗

Predicted impact: Low

Same dry AMD two-year trial result as the other item, reported by another outlet.

News · Money Today·

Y2 Solution announces 2-year follow-up results for dry AMD treatment: "vision improvement sustained"

Y2 Solution₩3,010▼6.38%
Read the original ↗

Predicted impact: Medium

Two-year follow-up for dry AMD therapy via US joint venture; early-stage, no revenue impact given.

News · Etoday·

Y2 Solutions Presents Phase 1/2a Clinical Results of Dry Macular Degeneration Cell Therapy at BIX 2026

Y2 Solution₩3,010▼6.38%
Read the original ↗

Predicted impact: Low· Actual: +36.2% vs sector, volume 2.3× normal (5 trading days)

Clinical trial results presentation at a conference; early-stage data with no financial size.

Also known as: Y2 Solution / 와이투솔루션 / 011690 / KRX:011690

Source: KRX statistical information